2. Forward‐Looking Statement
Statements in this presentation that relate to Park City Group's future plans, objectives,
expectations, performance, events and the like are "forward‐looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act
of 1934. Future events, risks and uncertainties, individually or in the aggregate, could cause
actual results to differ materially from those expressed or implied in these statements. Those
factors could include changes in economic conditions that may change demand for the
Company's products and services and other factors discussed in the "forward‐looking
information" section and the "risk factor" section of the management's discussion and analysis
included in the Company's report on Form 10‐K and 10‐Q or current reports on Form 8‐K filed
with the Securities and Exchange Commission. This presentation is comprised of interrelated
information that must be interpreted in the context of all of the information provided and care
should be exercised not to consider portions of this presentation out of context. Park City
Group uses paid services of investor relations organizations to promote the Company to the
investment community. Investments in any company should be considered speculative and
prior to acquisition, should be thoroughly researched. Park City Group does not intend to
update these forward‐looking statements prior to announcement of quarterly or annual
results.
2
Sell More – Stock Less – See Everything
4. Park City Group Investment Highlights
> Recurring revenue streams with multi‐year
visibility – ~90%+ customer retention rate
gives strong earnings visibility.
NYSE MKT: PCYG
Headquarters: Salt Lake City, Utah
Recent Price (11/12/13)
52‐Week Range
> Generating significant positive cash flow…
Significant operating leverage with 75%+
incremental margin. No need to raise capital.
$9.84
$2.71 ‐$9.94
Shares Outstanding
16.1 MM
Fully Diluted Shares
17.6 MM
Market Capitalization
$163.0 MM
TTM Revenue
$11.4 MM
> Accelerating growth & strong balance Sheet– TTM Adjusted‐EBITDA
$2.6 MM
Ownership
in both revenue and EPS due to recent
~40% Insider Ownership
national account wins.
> Strong competitive advantage – 16 years of development and ~$125 million
of invested capital in propriety platform.
> ReposiTrak™ partnership is well positioned to become the standard for
tracking and tracing food and drugs in the global supply chain.
> Influential board of directors and experienced management team – current
and former grocery, retailing, consumer products, dairy, and magazine
industry senior executives.
4
Sell More – Stock Less – See Everything
8. Park City Group Solutions
> Provide greater visibility into consumer demand
> Turn data into actionable information across the entire supply chain
> Enable collaboration between the Retailer and the Supplier (“collaborative
commerce”)
Customer Value Proposition
> Reduced out‐of‐stocks = Increase in sales 4% to 6%
> Lower Inventories / working capital – 10% to 30%
> Increased margins through greater logistic efficiency, inventory accuracy
and less promotional spending
8
Sell More – Stock Less – See Everything
15. Large Addressable Market
$550 million addressable U.S. market
> ~150 ‐ 200 Retailers
> ~100,000 total connections @ ~$5K each
Addressable Market
Additional supply chain management
services
Food &
Drug
Safety
> From basic service to enterprise supply
chain management
> Increase average rev. per connection
$1 billion+ food & drug safety
> 167,000 domestic manufactures,
processors, warehouses; 254,000 foreign
> 570,000 U.S. facilities in the food service
segment
> 2 million farmers / 5 million international
15
Additional
Services
[2x Base
Base Level Level]
Service
$550 million
Sell More – Stock Less – See Everything
22. Park City Group Investment Highlights
> Recurring revenue streams with multi‐year
visibility – ~90%+ customer retention rate
gives strong earnings visibility.
NYSE MKT: PCYG
Headquarters: Salt Lake City, Utah
Recent Price (11/12/13)
52‐Week Range
> Generating significant positive cash flow…
Significant operating leverage with 75%+
incremental margin. No need to raise capital.
$9.84
$2.71 ‐$9.94
Shares Outstanding
16.1 MM
Fully Diluted Shares
17.6 MM
Market Capitalization
$163.0 MM
TTM Revenue
$11.4 MM
> Accelerating growth & strong balance Sheet– TTM Adjusted‐EBITDA
$2.6 MM
Ownership
in both revenue and EPS due to recent
~40% Insider Ownership
national account wins.
> Strong competitive advantage – 16 years of development and ~$125 million
of invested capital in propriety platform.
> ReposiTrak™ partnership is well positioned to become the standard for
tracking and tracing food and drugs in the global supply chain.
> Influential board of directors and experienced management team – current
and former grocery, retailing, consumer products, dairy, and magazine
industry senior executives.
22
Sell More – Stock Less – See Everything
